DDL2019

Dr Omar Usmani

National Heart and Lung Institute (NHLI), Imperial College London & Royal Brompton Hospital

Implications for patient care and disease management

The environmental impact of MDI propellants – what now?

Dr John Pritchard

Private Consultant

Sustainable Inhalers – future challenges, threats and opportunities

Gregor Anderson

Consultant

Dr Stephanie Wright

UKRI Rutherford Fellow, Medical Research Council Centre for Environment and Health, King's College London

Inhaled microplastics: an unrecognised health issue?

Winning Conference Paper from DDL2014

Abhinav Kumar

Elsevier

Winner of the Pat Burnell Young Investigator Award in 2014

Winning Conference Paper from 2015

Dr Sumit Arora

Certara UK Limited

Winner of the Pat Burnell Young Investigator Award in 2015

Winning Conference Paper from 2010

Prof. Dr. Regina Scherließ

Kiel University

Winner of the Pat Burnell Young Investigator Award 2010

Alix Berton

Astrazeneca

The application of Precision Medicine and Genomics to enable new Respiratory medicines

The role of aerosols in preclinical drug development

Otmar Schmid

Helmholtz Zentrum München

Experimental evidence of regional lung deposition differences effecting the systemic exposure in dog

Ulrika Tehler

Astrazeneca

Computational and modelling approaches in dry powder inhaler product design

Dr Darragh Murnane

Professor of Pharmaceutics at the University of Hertfordshire

Jayne Hastedt

JDP Pharma Consulting

Classification of Inhaled Medicines: Development of an Inhalation-based Biopharmaceutical Classification System

Wendy Barclay

Imperial College London

Airborne transmission of influenza virus

Effect of the heated humidification on the in vitro aerosol delivery with a pressurized-metered dose inhaler and with a vibrating mesh nebulizer in mechanical ventilation

Thierry Poree

Laboratoire OptimHal-ProtecSom

Non-volatile Excipient effect on Inhaled Drug Product Performance

Precious Akhuemokhan

King’s College London

Inhalable mRNA dry powder formulation with PEGylated KL4 peptide delivery system

Yingshan Qiu

The University of Hong Kong

In vitro behaviour of konjac glucomannan microparticles aimed at pulmonary tuberculosis therapy

Filipa Guerreiro

University of Algarve

Can a combination of magnesium stearate and fines reach a higher inhalable fraction of a mannitol carrier based interactive blend?

Nancy Hertel

PhD Student, Kiel University

Incorporating Chemotherapeutic Drug into a Personalisable Silicone Airway Stent for the Treatment of Lung Cancer and Tracheobronchomalacia

Jesse Xu

Woolcock Institute of Medical Research

Training the Next Generation for Aerosol Science

Prof. Jonathan Reid

University of Bristol

Gary Anderson

Lung Health Research Centre, University of Melbourne

Inhaled Biologics for Respiratory Disorders

How spacers prove mysterious to patients

Sarah O’Connor

Asthma Society Ireland

Eosinophils in COPD: What is the story so far?

Prof. Mona Bafadhel

University of Oxford

Development and inhalation properties of Amikacin Liposome Inhalation Suspension (ALIS) for treatment of Mycobacterium avium complex (MAC) lung infections

Dr. Zhili Li

Insmed Incorporated

Aerosol drug delivery through the mouth to target nasal cavities: RETRONOSE® concept

Alain Regard

Nemera

Aerosol drug delivery through the mouth to target nasal cavities: RETRONOSE® concept

Laurent Vecellio

Nemera

Designing lipid nanoparticles for intranasal delivery of antidepressants

Matt Bonam

Global Head, Biopharma R&D Digital Patient Health, AstraZeneca

From Drug Product Characterization to Changing Patient Behaviours

Friday 13th December

Soraia Silva

University of Coimbra

Towards drug vaping: assessment of new-generation high-power electronic nicotine delivery system as thermal aerosol generation device for inhaled bronchodilators

Jérémie Pourchez

Mines Saint-Etienne

A validated theoretical approach to predict the effect of ambient temperature and ethanol concentration on the event-averaged pMDI droplet size

Barzin Gavtash

3M UK PLC